Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

PLx Pharma Inc. (PLXP)

5.6   -0.11 (-1.93%) 02-25 16:00
Open: 5.9 Pre. Close: 5.71
High: 5.9 Low: 5.45
Volume: 8,584 Market Cap: 51M
PLx Pharma Inc is a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard delivery system to provide safer and more effective aspirin products.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.903 - 5.934 5.934 - 5.957
Low: 5.384 - 5.414 5.414 - 5.437
Close: 5.552 - 5.603 5.603 - 5.642

Technical analysis

as of: 2020-02-25 4:32:32 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 6.96     One year: 8.13
Support: Support1: 4.97    Support2: 4.36
Resistance: Resistance1: 5.96    Resistance2: 6.96
Pivot: 5.55
Moving Average: MA(5): 5.61     MA(20): 5.54
MA(100): 4.85     MA(250): 5.29
MACD: MACD(12,26): 0.19     Signal(9): 0.20
Stochastic oscillator: %K(14,3): 64.63     %D(3): 60.18
RSI: RSI(14): 56.94
52-week: High: 7.41  Low: 3.25  Change(%): 18.6
Average Vol(K): 3-Month: 975  10-Days: 365

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
PLXP has closed below upper band by 42.8%. Bollinger Bands are 24.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

PLx Pharma Inc. to Present at Biotech Showcase 2020 | MarketScreener
SPARTA, N.J., Jan. 07, 2020 -- PLx Pharma Inc. , a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard™… | January 7, 2020

PLx Pharma Provides Regulatory Update on VAZALORE
PLx Pharma announced that the US Food and Drug Administration (FDA) is providing clarification for the regulatory path forward for VAZALORE. The post PLx Pharma Provides Regulatory Update on VAZALORE appeared first on Investing News Network .

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 9.15
Shares Float (M) 7.47
% Held by Insiders 2.30
% Held by Institutions 22.32
Shares Short (K) 167
Shares Short P. Month (K)

Stock Financials

EPS -3.290
Book Value (p.s.) -1.120
PEG Ratio -0.03
Profit Margin
Operating Margin -1563.87
Return on Assets (ttm) -37.1
Return on Equity (ttm) -409.7
Qtrly Rev. Growth -81.0
Gross Profit (p.s.) 0.082
Sales Per Share
EBITDA (p.s.) -1.398
Qtrly Earnings Growth
Operating Cash Flow (M) -11.31
Levered Free Cash Flow (M) -7.08

Stock Valuations

P/E -1.70
P/E Growth Ratio -0.03
P/BV -5.00
P/S 62.22
P/CF -4.53

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2017-04-19
Last Split Ratio 0.13
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.